3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

You are here : 3-RX.com > Drugs & Medications > Detailed Drug Information (USP DI) > Immune Globulin Intravenous (Human) : Additional Information

Immune Globulin Intravenous (Human) (Systemic)

Brand Names : Gamimune N 5%, Gamimune N 10%, Gamimune N 5% S/D, Gamimune N 10% S/D, Gammagard S/D, Gammagard S/D 0.5 g, Gammar-P IV, Iveegam, Panglobulin, Polygam S/D, Sandoglobulin, Venoglobulin–I, Venoglobulin-S, IGIV, IVIG

Immune Globulin Intravenous (Human) | Before Using | Proper Use | Side Effects | Additional Information

Additional Information

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, IGIV is used in certain patients with the following medical conditions:

  • Chronic parvovirus B19 infection (treatment)
  • Chronic inflammatory demyelinating polyneuropathies (treatment)
  • Dermatomyositis (treatment)
  • Guillain-Barré syndrome (treatment)
  • Hyperimmunoglobulinemia E syndrome (treatment)
  • Infections in low-birth-weight preterm high-risk neonates (prophylaxis and treatment adjunct)
  • Lambert-Eaton myasthenic syndrome (treatment)
  • Multifocal motor neuropathy (treatment)
  • Relapsing-remitting multiple sclerosis (treatment)

Other than the above information, there is no additional information relating to proper use, precautions, or side effects for its use.

Previous section


Immune Globulin Intravenous (Human): Side Effects


\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site